{"schema_version":"secwatch.filing_event.v1","accession":"0001140361-22-041531","form_type":"8-K","ticker":"SNWV","cik":"0001417663","company_name":"SANUWAVE Health, Inc.","filed_at":"2022-11-15T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.575002+00:00","generated_at":"2026-06-21T18:21:51.845975+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.7,"calibrated_materiality_score":0.7,"confidence":"high","headline":"SANUWAVE Q3 revenue $4.2M (+12% YoY); gross margin 85%; turns EBITDA positive in October","bullets":["Q3 revenue $4.2M, +12% YoY; nine-month revenue $11.2M, +28.5% YoY.","Gross margin improved to 85% from 58% YoY; nine-month margin 77% vs 58%.","Operating loss narrowed to $1.8M from $3.4M YoY; nine-month operating expense down 17.6%.","Company became EBITDA positive in October 2022 and expects Q4 profitability.","Post-quarter raised ~$2M for sales hiring and inventory; terms consistent with August financing."],"urls":{"canonical":"https://secwatch.observer/filing/0001140361-22-041531","json":"https://secwatch.observer/filing/0001140361-22-041531.json","markdown":"https://secwatch.observer/filing/0001140361-22-041531.md","text":"https://secwatch.observer/filing/0001140361-22-041531.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/0001140361-22-041531-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/brhc10044117_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-21T18:21:51.845975+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"3819d565b385a217faa1e56acd0de021eac8133b","claim":"SANUWAVE Health, Inc. reported the quarter, starting April 1, 2022 and ending June 30, 2022 results: revenue $3.9 million.","evidence_excerpt":"Revenues for the quarter, starting April 1, 2022 and ending June 30, 2022, came in at $3.9 million.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/0001140361-22-041531-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the quarter, starting April 1, 2022 and ending June 30, 2022"},{"label":"Revenue","value":"$3.9 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"},{"claim_id":"cd065371a68f7d9e34f93db55e202904e5d04382","claim":"SANUWAVE Health, Inc. reported the 3 months ended September 30, 2022 results: revenue $4.2 million.","evidence_excerpt":"Revenues increased 12% to $4.2 million for the 3 months ended September 30, 2022, versus $3.7 million for the same period last year.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1417663/000114036122041531/0001140361-22-041531-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the 3 months ended September 30, 2022"},{"label":"Revenue","value":"$4.2 million"},{"label":"Result","value":"reported results"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}